None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Healthy Japanese Males aged 20 to 40 years-old. 2) Subjects whose BMI are under 30. 3) Subjects who can make self-judgment and are voluntarily giving written informed consent.
Exclusion criteria
Exclusion criteria: Subjects (who) 1)regularly use drugs associated with muscle and/or lipid metabolism 2)contract or have a history of serious diseases(eg, liver, kidney, digestive, heart, respiratory, endocrine, metabolic, skeletal muscle and/or tendon disease) 3)are undergoing or may receive surgical treatment of knee joints 4)with pacemaker or artificial joint, etc. 5)have had severe damage on the locomotive organs such as fracture, tendon rupture, or muscle strain in the past 1 year 6)with physical disabilities such as severe low back pain and knee pain, which interfere with exercise 7)contract or have a surgical history of digestive disease affecting digestion and absorption 8)can't stop using supplements, and/or functional foods (including Food for Specified Health Uses, Foods with Function Claims or nutritional supplements which contain amino acids and/or proteins) 9)whose exercise is prohibited by doctors 10)declared allergic reactions to foods 11) can't stop drinking from 2 days before each measurement 12) have alcohol intake more than approximately 20 g/day of pure alcohol equivalent or a habit of drinking not less than 4 days a week 13)are shiftworker and/or midnight-shift worker 14)with a history of and/or current drug addiction and/or alcoholism 15)were judged as unsuitable for the current study by screening tests 16) have donated over 200 mL of blood and/or blood components within the last one month prior to the current study or over 400 mL of blood and/or blood components within the last three months prior to the current study 17)are participating in or willing to participate in other clinical studies 18)were judged as unsuitable for the current study by the investigator for other reasons
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Muscle mass | — |
Secondary
| Measure | Time frame |
|---|---|
| Muscle strength | — |
Countries
Japan
Contacts
KSO Corporation Clinical Trial Management department